These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 23503546)

  • 1. Effect of nicotine on the pharmacokinetics of levodopa.
    Kyaw WT; Nagai M; Kaneta M; Kubo M; Nishikawa N; Tsujii T; Iwaki H; Nomoto M
    Clin Neuropharmacol; 2013; 36(2):46-51. PubMed ID: 23503546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of smoking cessation on gastric emptying in smokers.
    Kadota K; Takeshima F; Inoue K; Takamori K; Yoshioka S; Nakayama S; Abe K; Mizuta Y; Kohno S; Ozono Y
    J Clin Gastroenterol; 2010 Apr; 44(4):e71-5. PubMed ID: 20305466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of co-administration of benzhexol on the peripheral pharmacokinetics of oral levodopa in young volunteers.
    Roberts J; Waller DG; von Renwick AG; O'Shea N; Macklin BS; Bulling M
    Br J Clin Pharmacol; 1996 Apr; 41(4):331-7. PubMed ID: 8730980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic-pharmacodynamic modeling of levodopa in patients with advanced Parkinson disease.
    Adamiak U; Kaldonska M; Klodowska-Duda G; Wyska E; Safranow K; Bialecka M; Gawronska-Szklarz B
    Clin Neuropharmacol; 2010 May; 33(3):135-41. PubMed ID: 20216409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levodopa peak delay and impaired gastric emptying in Parkinson's disease.
    Doi H; Sakakibara R; Sato M; Masaka T; Kishi M; Tateno A; Tateno F; Tsuyusaki Y; Takahashi O
    J Neurol Sci; 2012 Aug; 319(1-2):86-8. PubMed ID: 22632782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
    Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastric emptying in healthy volunteers after multiple doses of levodopa.
    Waller DG; Roseveare C; Renwick AG; Macklin B; George CF
    Br J Clin Pharmacol; 1991 Dec; 32(6):691-5. PubMed ID: 1768561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic-pharmacodynamic interaction between nebicapone and controlled-release levodopa/benserazide: a single-center, Phase I, double-blind, randomized, placebo-controlled, four-way crossover study in healthy subjects.
    Nunes T; Machado R; Rocha JF; Fernandes-Lopes C; Costa R; Torrão L; Loureiro AI; Falcão A; Vaz-da-Silva M; Wright L; Almeida L; Soares-da-Silva P
    Clin Ther; 2009 Oct; 31(10):2258-71. PubMed ID: 19922897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral amino acids and gastric emptying: an investigation of the mechanism of levodopa-induced gastric stasis.
    Waller DG; Usman F; Renwick AG; Macklin B; George CF
    Br J Clin Pharmacol; 1991 Dec; 32(6):771-3. PubMed ID: 1768574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine reduces levodopa-induced dyskinesias in lesioned monkeys.
    Quik M; Cox H; Parameswaran N; O'Leary K; Langston JW; Di Monte D
    Ann Neurol; 2007 Dec; 62(6):588-96. PubMed ID: 17960553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body weight, levodopa pharmacokinetics and dyskinesia in Parkinson's disease.
    Arabia G; Zappia M; Bosco D; Crescibene L; Bagalà A; Bastone L; Caracciolo M; Scornaienghi M; Quattrone A
    Neurol Sci; 2002 Sep; 23 Suppl 2():S53-4. PubMed ID: 12548340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central levodopa influx and the clinical motor response to levodopa in patients with Parkinson disease complicated with motor fluctuations and dyskinesias.
    López-Ariztegui N; Arévalo MA; de Ceballos ML; Grandas F
    Clin Neuropharmacol; 2009; 32(6):321-5. PubMed ID: 19667975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irregular gastrointestinal drug absorption in Parkinson's disease.
    Nyholm D; Lennernäs H
    Expert Opin Drug Metab Toxicol; 2008 Feb; 4(2):193-203. PubMed ID: 18248312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative bioavailability of 2 tablet formulations of levodopa/benserazide in healthy, fasting volunteers: a single-dose, randomized-sequence, open-label crossover study.
    Keller GA; Czerniuk P; Bertuola R; Spatz JG; Assefi AR; Di Girolamo G
    Clin Ther; 2011 Apr; 33(4):500-10. PubMed ID: 21635995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subthalamic deep brain stimulation can improve gastric emptying in Parkinson's disease.
    Arai E; Arai M; Uchiyama T; Higuchi Y; Aoyagi K; Yamanaka Y; Yamamoto T; Nagano O; Shiina A; Maruoka D; Matsumura T; Nakagawa T; Katsuno T; Imazeki F; Saeki N; Kuwabara S; Yokosuka O
    Brain; 2012 May; 135(Pt 5):1478-85. PubMed ID: 22522940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic comparison of two nicotine transdermal systems, a 21-mg/24-hour patch and a 25-mg/16-hour patch: a randomized, open-label, single-dose, two-way crossover study in adult smokers.
    DeVeaugh-Geiss AM; Chen LH; Kotler ML; Ramsay LR; Durcan MJ
    Clin Ther; 2010 Jun; 32(6):1140-8. PubMed ID: 20637967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent vs continuous levodopa administration in patients with advanced Parkinson disease: a clinical and pharmacokinetic study.
    Stocchi F; Vacca L; Ruggieri S; Olanow CW
    Arch Neurol; 2005 Jun; 62(6):905-10. PubMed ID: 15956161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levodopa pharmacokinetics and dyskinesias: are there sex-related differences?
    Martinelli P; Contin M; Scaglione C; Riva R; Albani F; Baruzzi A
    Neurol Sci; 2003 Oct; 24(3):192-3. PubMed ID: 14598082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of levodopa/carbidopa microtablets versus levodopa/benserazide and levodopa/carbidopa in healthy volunteers.
    Nyholm D; Lewander T; Gomes-Trolin C; Bäckström T; Panagiotidis G; Ehrnebo M; Nyström C; Aquilonius SM
    Clin Neuropharmacol; 2012; 35(3):111-7. PubMed ID: 22549097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and bioavailability of Sinemet CR: a summary of human studies.
    Yeh KC; August TF; Bush DF; Lasseter KC; Musson DG; Schwartz S; Smith ME; Titus DC
    Neurology; 1989 Nov; 39(11 Suppl 2):25-38. PubMed ID: 2685649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.